SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-043745
Filing Date
2013-08-08
Accepted
2013-08-07 21:58:46
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v349870_10q.htm 10-Q 335533
2 EX-31.1 v349870_ex31-1.htm EX-31.1 11521
3 EX-31.2 v349870_ex31-2.htm EX-31.2 11433
4 EX-32.1 v349870_ex32-1.htm EX-32.1 5813
5 EX-32.2 v349870_ex32-2.htm EX-32.2 5760
  Complete submission text file 0001144204-13-043745.txt   4735160

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pip-20130630.xml EX-101.INS 357046
7 XBRL TAXONOMY EXTENSION SCHEMA pip-20130630.xsd EX-101.SCH 41491
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pip-20130630_cal.xml EX-101.CAL 41373
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pip-20130630_def.xml EX-101.DEF 137934
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pip-20130630_lab.xml EX-101.LAB 555600
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pip-20130630_pre.xml EX-101.PRE 220518
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 131019772
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences